Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma
Authors
Keywords
-
Journal
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 22, Issue 4, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-16
DOI
10.1007/s11864-021-00826-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial
- (2020) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- CME Part I: Immune checkpoint inhibitors to treat cutaneous malignancies
- (2020) Dulce M. Barrios et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- “Efficacy and safety of panitumumab alone or in association with radiotherapy in unresectable cutaneous squamous-cell carcinoma”
- (2020) K Hourbeigt et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Clinical Management of Locally Advanced Basal-Cell Carcinomas and Future Therapeutic Directions
- (2020) Dennis Niebel et al. Dermatology and Therapy
- Photodynamic therapy in dermatology: Beyond current indications
- (2020) Catarina Queirós et al. Dermatologic Therapy
- Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)
- (2020) Jean-Jacques Grob et al. JOURNAL OF CLINICAL ONCOLOGY
- Is the first-line treatment of keratoacanthomas surgical excision or injection of intralesional chemotherapy?
- (2020) Karl M. Hoegler et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
- (2019) Paul Nghiem et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of radiotherapy in the management of non‐melanoma skin cancer
- (2019) Kieran B Garbutcheon‐Singh et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Two controversies confronting dermoscopy or dermatoscopy: nomenclature and results
- (2019) Claudio Conforti et al. CLINICS IN DERMATOLOGY
- Dermoscopy and the experienced clinicians
- (2019) Claudio Conforti et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- PD-1 and PD-L1 inhibitors in the treatment of non-melanoma skin cancer: a systematic review
- (2019) Franchesca D. Choi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Immune Checkpoint Inhibitor Toxicities
- (2019) Julian A. Marin-Acevedo et al. MAYO CLINIC PROCEEDINGS
- Current Role of Radiotherapy in Non-melanoma Skin Cancer
- (2019) M.J. Veness et al. CLINICAL ONCOLOGY
- Evolving Role of Systemic Therapies in Non-melanoma Skin Cancer
- (2019) C. Conforti et al. CLINICAL ONCOLOGY
- Electrochemotherapy and Ablative Therapies in Non-melanoma Skin Cancer
- (2019) N. O'Donoghue et al. CLINICAL ONCOLOGY
- Toxicities associated with checkpoint inhibitors—an overview
- (2019) Laura Spiers et al. RHEUMATOLOGY
- Use of noninvasive imaging in the management of skin cancer
- (2019) Roberta Giuffrida et al. CURRENT OPINION IN ONCOLOGY
- Medical treatment of advanced cutaneous squamous‐cell carcinoma
- (2019) F.F. Gellrich et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial
- (2018) Kathryn A. Gold et al. CANCER
- Emerging Nonsurgical Therapies for Locally Advanced and Metastatic Nonmelanoma Skin Cancer
- (2018) Leon Chen et al. DERMATOLOGIC SURGERY
- Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
- (2018) S. Cavalieri et al. EUROPEAN JOURNAL OF CANCER
- PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
- (2018) Michael R. Migden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab
- (2018) Alessandra Chen et al. Journal of Clinical Medicine
- Pembrolizumab as first line therapy in patients with unresectable squamous cell carcinoma of the skin: Interim results of the phase 2 CARSKIN trial.
- (2018) Eve Maubec et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study
- (2018) Anne Lynn S. Chang et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Update on Keratinocyte Carcinomas
- (2018) Kishwer S. Nehal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cemiplimab: First Global Approval
- (2018) Anthony Markham et al. DRUGS
- Cetuximab‐radiotherapy combination in the management of locally advanced cutaneous squamous cell carcinoma
- (2018) Kurian Joseph et al. Journal of Medical Imaging and Radiation Oncology
- Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
- (2017) N. Basset-Séguin et al. EUROPEAN JOURNAL OF CANCER
- Durable Response of Metastatic Squamous Cell Carcinoma of the Skin to Ipilimumab Immunotherapy
- (2017) Fiona Day et al. JOURNAL OF IMMUNOTHERAPY
- Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial
- (2017) William N. William et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study
- (2017) J.T. Lear et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma
- (2017) Duy C. Tran et al. JAMA Dermatology
- Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab
- (2017) Mary L. Stevenson et al. JAMA Dermatology
- Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab
- (2017) Alexandra Picard et al. JAMA Dermatology
- Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC)
- (2016) Anthony Jarkowski et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases
- (2016) L. Borradori et al. BRITISH JOURNAL OF DERMATOLOGY
- A clinical drug–drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib
- (2016) Vikram Malhi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer
- (2016) Giulia Bertino et al. EUROPEAN JOURNAL OF CANCER
- RECIST 1.1—Update and clarification: From the RECIST committee
- (2016) Lawrence H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC)
- (2016) Gina P. Kwon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review
- (2016) Lauren Metterle et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
- (2016) Gerald S. Falchook et al. Journal for ImmunoTherapy of Cancer
- Head and Neck Non-Melanoma Skin Cancer Treated By Superficial X-Ray Therapy: An Analysis of 1021 Cases
- (2016) Daniel Grossi Marconi et al. PLoS One
- Efficacy of neoadjuvant cetuximab alone or with platinum salt for the treatment of unresectable advanced nonmetastatic cutaneous squamous cell carcinomas
- (2015) M. Reigneau et al. BRITISH JOURNAL OF DERMATOLOGY
- Sonidegib: First Global Approval
- (2015) Celeste B. Burness DRUGS
- Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC
- (2015) Aleksandar Sekulic et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a comparative cohort study
- (2015) R. Salido-Vallejo et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
- (2015) Nicole Basset-Seguin et al. LANCET ONCOLOGY
- Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma
- (2015) Erqi L. Pollom et al. JAMA Dermatology
- Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012
- (2015) Howard W. Rogers et al. JAMA Dermatology
- Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma
- (2014) M. C. Foote et al. ANNALS OF ONCOLOGY
- Cetuximab in non-melanoma skin cancer
- (2012) Uwe Wollina EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy of cetuximab in the treatment of squamous cell carcinoma
- (2012) Sophie Preneau et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemotherapy of Squamous Cell Carcinoma of the Skin
- (2012) Ronald C. DeConti SEMINARS IN ONCOLOGY
- Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin
- (2011) Eve Maubec et al. JOURNAL OF CLINICAL ONCOLOGY
- Intralesional chemotherapy for nonmelanoma skin cancer: A practical review
- (2010) Joslyn S. Kirby et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- (2009) Jorg Hartmann et al. CURRENT DRUG METABOLISM
- Neoadjuvant polychemotherapy in locally advanced Merkel cell carcinoma
- (2009) Thomas Jouary et al. Nature Reviews Clinical Oncology
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Photodynamic Therapy in Dermatology – an Update 2008
- (2008) Annette Klein et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now